Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2013; 19(14): 2256-2261
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2256
Figure 3
Figure 3 Cumulative incidence of disease progression according to changes in alanine aminotransferase levels. The incidence rate differed among patients who exhibited persistently “low-normal” alanine aminotransferase (ALT) levels or “high-normal” ALT levels and patients who exhibited ALT elevation (> 41 IU/L) during follow-up.